|By PR Newswire||
|March 10, 2014 02:29 PM EDT||
LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
This research service provides a list of key technology trends in health and wellness that are likely to have an impact in the year 2013 until 2017. The slides provide a brief snapshot of the technology, the key benefits or strengths, trends and initiatives, key stakeholders and their solutions, applications, enabling technologies, insights and recommendations as applicable for the identified list of technologies.
Research Scope and Index
Top Technology Trends:
Targeted Drug Delivery
Recombinant Expression Systems
Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2013.
The slides provide information on the following lines on a best effort basis, as applicable to the technology under consideration.
They are as follows:
• Brief Snapshot of the Technology
• Recent Developments
• Key Stakeholders and their Solutions
• Future Scenario
•Strategic Decision Makers
•Technology Policy Heads
•Market Research Reports
•Technology Policy information Sites
•Thought Leader Briefings
Personalized medicine involves the study of human diseases at molecular level, pairing the advances in molecular diagnostics, along with genomics based drug development. Particular treatment design according to the individual's genome and epigenome is the goal.
As the aging population grows and seeks more services for disease screening, diagnosis and monitoring, the demand for novel life sciences tools increases.
•Personalized medicine (PM) aims to characterize disease at different levels and evolution stages to target specific genes or molecular pathways.
•Miniaturized, wireless, implantable sensors, are finding increased opportunities to more conveniently provide real-time information about a patient's condition.
•Omics-based technologies have revolutionized life sciences research and biomedical engineering, by generating huge amounts of information.
•Important efforts are being conducted toward becoming this information in valuable insights for clinical and biomedical routine tools for early diagnostics and prognostics.
Year of Impact
•Personalized medicine involves an evolving challenge from part of a broad spectrum of fields of research covering both sciences traditionally contributing to medicine and healthcare advances, such as genetics, biology, and pharmacology, and their -omics related fields, that is, proteomics, transcriptomics, metabonomics, and so on.
•More recently contributing sciences, such as bioinformatics, robotics, nanobiotechnology, mechatronics, and biomics, also play a critical role in the impact of personalized medicine in the human health.
•A solid convergence of these technologies is expected by 2016 for commercialization and 2018 for wide scale adoption.
•Personalized medicine (PM) deeply digs inside the study of human diseases at molecular level, pairing the advances in molecular diagnostics, as well as, genomics based drug development. The aim of PM is to harmonize the relation between treatment and patient, taking into consideration the individual variations that lead to a specific behavior and drug response, could even involve the particular treatment design according to the individual genotype among other features.
•Toward this concept, coined terms as stratified medicine and integrated healthcare attempt to cover developments in genomics-based personalized medicines for different clusters, predisposition testing, preventive medicine, combination of diagnostics with therapeutics, and monitoring of therapy.
•A new vision attempting to avoid costly and prolonged trial and error approaches, while precluding treatment side effects, in conjunction with significant gain time, is being achieved.
•Personalized diagnostics and therapeutics
•Response drug evaluation and screening for new, more specific molecular entities
•Facing rare disease challenges for novel solutions
•Addressing autoimmune and inflammatory diseases therapies
•Attrition rate, risk, cost and time reduction
•Use of virtual clinical trials and more caution experimental design for stratified groups
•Holistic view of human health
•New niches for molecular entities
Technology Roadmap (2000-2020)
1. Stratified Medicine
Gene expression/disease correlation
Pathways modeling/simulation and biomarkers development
Focus on cancer research
In silico, in vitro, in vivo models for experimental design and clinical trials
2. Personalized Theranostics
Single molecule biosensors
Systems biology/Modeling and simulation
Micro/nanotech for cancer/infectious diseases diagnostics
Flexible assay platform (platform independence)
Multipanel biomarker assays
3. Virtual Patients
Virtual populations for clinical trials
Disease prediction and risk management
Targeted tumor therapeutics
Epigenome-based tech platforms
In silico early diagnostic tests
Pathway regulation therapeutics
Circulating customized microvesicle-based cancer testing
Technology Development and Adoption Footprint
Pioneering in PM, the US possess one of the strongest R&D networks, counting with solid and well established public and private funding sources
The EU is remarkable promoting the advancement of PM approaches through its numerous FP7 programmes. In turn, national ecosystems are also emerging
Japan, India and Australia lead the development of PM, not only in a direct manner, but also promoting the development of enabling cutting-edge technologies
Marshfield Clinic, Wisconsin, US: Establishment of the Center for Medical Genetics, Personalized Medicine Research Center, Personalized Medicine Research Project (PMRP), Wisconsin Genomics Initiative (WGI). University of California San Francisco (UCSF), US: Collaboration line with Kaiser Permanente (an insurance company) to expand its existing data bank of clinical information to include genetic sequencing information. Launch of the Research Program on Genes, Environment and Health (RPGEH) initiative, and the Pharmacogenomics Research Network'(PGRN). University of Chicago, US: Launch of the 1200 Patients Project to pave the way for introducing the PM approach in the clinical routine. Mayo Clinic;, US: Creation of the Center for Individualized Medicine, with its Translational and Infrastructure programmes. Etc.
Indiana Center for Systems Biology and Personalized Medicine, Center for Integration of Medicine & Innovative Technology (CIMIT)-Massachusetts General Hospital (MGH), Integrated Biobank of Luxembourg (IBBL), Fraunhofer Institute for Systems and Innovation Research, Institut national de la santé et de la recherche médicale (Inserm), The Institute for Personalized Respiratory Medicine of the University of Illinois Hospital and Health Sciences System, Interuniversity Microelectronics Centre(IMEC), etc.
Affymetrix, Cynvenio, DNA Genotek, Genia, Illumina, Life Technologies, Amgen, Astellas, BI, BMS, Eli Lilly, EMD Serono, Endo Health Solutions, GE, GSK, J&J, Merck, Millennium, Novartis, Pfizer, Atossa Genetics, Fluxion, Nodality, 23andMe, Cureline, Genophen, iSpecimen, N-of-One, Selventa, Kinemed, etc.
Government Agencies/Funding Bodies
Agencies financially supporting PM projects: The Biomedical Information Science and Technology Initiative (NIH/BISTI), National Institute of General Medical Sciences (NIH/NIGMS), Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS), Small Business Innovation Research (SBIR), Small Business Technology Transfer Program (STTR), European Commission (EU), European Research Council (ERC), European Science Foundation (ESF), European Association for Predictive, Preventive and Personalised Medicine (EPMA), European Organisation of Personalised Medicine (EPEMED), Asia-Pacific Economic Cooperation (APEC), which through their multiple framework programmes hold strong focus on PM envisioning 2020. VCs: Burrill & Company, Kleiner Perkins Caufield & Byers, Mohr Davidow, Pappas Ventures, Third Rock Ventures, LLC
Regulators/ Associations/Standardization Bodies
FDA and EMA have issued draft guidelines on registration and approval procedures regarding patient populations stratification to facilitate targeted therapy.
Table of Contents
Executive Summary 3
Personalized Medicine 6
Targeted Drug Delivery 16
Regenerative Medicine 26
Next-Generation Prebiotics 46
Nutrient Encapsulation 51
Nanoparticle-based Therapies 56
Next-Generation Sequencing 66
Recombinant Expression Systems 72
The Frost & Sullivan Story 77
Read the full report:
Top Technologies in Health and Wellness
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Apr. 29, 2017 07:15 AM EDT Reads: 1,678
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
Apr. 29, 2017 07:15 AM EDT Reads: 1,445
Everyone wants to use containers, but monitoring containers is hard. New ephemeral architecture introduces new challenges in how monitoring tools need to monitor and visualize containers, so your team can make sense of everything. In his session at @DevOpsSummit, David Gildeh, co-founder and CEO of Outlyer, will go through the challenges and show there is light at the end of the tunnel if you use the right tools and understand what you need to be monitoring to successfully use containers in your...
Apr. 29, 2017 05:45 AM EDT Reads: 2,258
SYS-CON Events announced today that Super Micro Computer, Inc., a global leader in compute, storage and networking technologies, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology, is a premier provider of advanced server Building Block Solutions® for Data Center, Cloud Computing, Enterprise IT, Hadoop/...
Apr. 29, 2017 05:30 AM EDT Reads: 2,515
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Apr. 29, 2017 05:00 AM EDT Reads: 1,493
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Apr. 29, 2017 04:15 AM EDT Reads: 899
Judith Hurwitz is president and CEO of Hurwitz & Associates, a Needham, Mass., research and consulting firm focused on emerging technology, including big data, cognitive computing and governance. She is co-author of the book Cognitive Computing and Big Data Analytics, published in 2015. Her Cloud Expo session, "What Is the Business Imperative for Cognitive Computing?" is scheduled for Wednesday, June 8, at 8:40 a.m. In it, she puts cognitive computing into perspective with its value to the busin...
Apr. 29, 2017 04:00 AM EDT Reads: 3,808
NHK, Japan Broadcasting, will feature the upcoming @ThingsExpo Silicon Valley in a special 'Internet of Things' and smart technology documentary that will be filmed on the expo floor between November 3 to 5, 2015, in Santa Clara. NHK is the sole public TV network in Japan equivalent to the BBC in the UK and the largest in Asia with many award-winning science and technology programs. Japanese TV is producing a documentary about IoT and Smart technology and will be covering @ThingsExpo Silicon Val...
Apr. 29, 2017 02:30 AM EDT Reads: 9,353
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
Apr. 29, 2017 01:45 AM EDT Reads: 1,293
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Apr. 29, 2017 01:45 AM EDT Reads: 1,582
Building a cross-cloud operational model can be a daunting task. Per-cloud silos are not the answer, but neither is a fully generic abstraction plane that strips out capabilities unique to a particular provider. In his session at 20th Cloud Expo, Chris Wolf, VP & Chief Technology Officer, Global Field & Industry at VMware, will discuss how successful organizations approach cloud operations and management, with insights into where operations should be centralized and when it’s best to decentraliz...
Apr. 29, 2017 01:15 AM EDT Reads: 927
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
Apr. 29, 2017 12:30 AM EDT Reads: 951
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
Apr. 29, 2017 12:00 AM EDT Reads: 1,062
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Apr. 29, 2017 12:00 AM EDT Reads: 993
@DevOpsSummit at Cloud taking place June 6-8, 2017, at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developm...
Apr. 28, 2017 11:45 PM EDT Reads: 2,387